Stock Events

Stock Events

Quantum BioPharma 

$4.85
142
+$0.55+12.79% Wednesday 06:41

Statistics

Day High
4.95
Day Low
4.75
52W High
-
52W Low
-
Volume
470
Avg. Volume
-
Mkt Cap
18.51M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Q3 2025
Next
-2.66
-2.07
-1.48
-0.89
Expected EPS
-0.8874492264
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-28.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QNTM.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same market as FSD Pharma.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with FSD Pharma in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, competing in the same industry as FSD Pharma.
Green Thumb Industries
GTBIF
Mkt Cap1.65B
Green Thumb Industries is involved in the cultivation, sale, and distribution of cannabis products, making it a competitor in the cannabis industry alongside FSD Pharma.

About

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
Show more...
CEO
Raza Bokhari
Employees
17
Country
CA
ISIN
CA74764Y2050

Listings

CN
CA
QNTM.CN
XNAS
US
QNTM
BOATS
BOATS
QNTM.BOATS
F
DE
0K91.F

0 Comments

Share your thoughts

FAQ

What is Quantum BioPharma stock price today?▼
The current price of QNTM.BOATS is $4.85 USD — it has increased by +12.79% in the past 24 hours. Watch Quantum BioPharma stock price performance more closely on the chart.
What is Quantum BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum BioPharma stocks are traded under the ticker QNTM.BOATS.
What is Quantum BioPharma market cap?▼
Today Quantum BioPharma has the market capitalization of 18.51M
When is the next Quantum BioPharma earnings date?▼
Quantum BioPharma is going to release the next earnings report on May 08, 2026.
What were Quantum BioPharma earnings last quarter?▼
QNTM.BOATS earnings for the last quarter are -1.26 USD per share, whereas the estimation was -2.66 USD resulting in a +52.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quantum BioPharma revenue for the last year?▼
Quantum BioPharma revenue for the last year amounts to 0 USD.
What is Quantum BioPharma net income for the last year?▼
QNTM.BOATS net income for the last year is -28.41M USD.
How many employees does Quantum BioPharma have?▼
As of April 04, 2026, the company has 17 employees.
In which sector is Quantum BioPharma located?▼
Quantum BioPharma operates in the Professional, Scientific, and Technical Services sector.
When did Quantum BioPharma complete a stock split?▼
The last stock split for Quantum BioPharma was on October 27, 2025 with a ratio of 2:1.
Where is Quantum BioPharma headquartered?▼
Quantum BioPharma is headquartered in Toronto, CA.